Fig. 14.1
3D anatomy of the left atrium with the Rhythmia System (posterior-anterior- and left lateral view). In both pictures you can see the multipolar mapping catheter (Orion) in the left superior pulmonary vein and the ablation catheter at the ostium of the PV during circumferential pulmonary vein isolation
[6].
Take Home Message
Most importantly, oral anticoagulation is essential in prevention of thromboembolism. Since it does not lead to an increased risk of bleeding events in women, oral anticoagulation should be emphasized more in practice. In addition, AF ablation should be recommended to women more often and at an earlier stage to increase the ablation success and to reduce the amount of women taking antiarrhythmic medication.
References
1.
Baman TS, Jongnarangsin K, Chugh A, Suwanagool A, Guiot A, Madenci A, Walsh S, Ilg KJ, Gupta SK, Latchamsetty R, Bagwe S, Myles JD, Crawford T, Good E, Bogun F, Pelosi Jr F, Morady F, Oral H. Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22(6):626–31. doi:10.1111/j.1540-8167.2010.01995.x.CrossRefPubMedPubMedCentral
2.
Bhave PD, Lu X, Girotra S, Kamel H, Vaughan Sarrazin MS. Race- and gender-related differences in care for patients newly diagnosed with atrial fibrillation. Heart Rhythm. 2015. doi:10.1016/j.hrthm.2015.03.031.PubMedPubMedCentral
3.
Calkins H, Kuck KH, Cappato R, Brugada J, Camm a J, Chen S-A, Crijns HJ, Damiano Jr RJ, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a re. Heart Rhythm. 2012;9(4):632–96. doi:10.1016/j.hrthm.2011.12.016.CrossRefPubMed
4.
Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369–429. doi:10.1093/eurheartj/ehq278.CrossRefPubMed
5.
Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Lévy S, Cobbe S, Kremastinos DT, Breithardt G, Cokkinos DV, Crijns HJGM. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe. A report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol. 2007;49(5):572–7. doi:10.1016/j.jacc.2006.10.047.CrossRefPubMed
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
